Temasek Holdings’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

Temasek Holdings’s Portfolio ASLN Stock Details ASLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,960	Closed	-$8.19K	–	108
2023 Q4	$8.19K	Sell	1,960 -39,992	-95%	-$302K	﹤0.01%	101
2023 Q3	$631K	Hold	41,952	–	–	﹤0.01%	79
2023 Q2	$1.22M	Hold	41,952	–	–	0.01%	67
2023 Q1	$967K	Hold	41,952	–	–	0.01%	65
2022 Q4	$604K	Hold	41,952	–	–	﹤0.01%	70
2022 Q3	$1M	Hold	41,952	–	–	0.01%	75
2022 Q2	$831K	Hold	41,952	–	–	﹤0.01%	91
2022 Q1	$1.51M	Hold	41,952	–	–	0.01%	87
2021 Q4	$1.88M	Hold	41,952	–	–	0.01%	86
2021 Q3	$2.99M	Hold	41,952	–	–	0.01%	75
2021 Q2	$5.54M	Hold	41,952	–	–	0.02%	78
2021 Q1	$5.62M	Hold	41,952	–	–	0.02%	61
2020 Q4	$3.07M	Buy	41,952 +6,390	+18%	+$469K	0.01%	68
2020 Q3	$2.7M	Hold	35,562	–	–	0.01%	65
2020 Q2	$2.85M	Hold	35,562	–	–	0.02%	50
2020 Q1	$1.45M	Hold	35,562	–	–	0.01%	55
2019 Q4	$2.89M	Hold	35,562	–	–	0.02%	52
2019 Q3	$2.46M	Hold	35,562	–	–	0.02%	52
2019 Q2	$4.37M	Hold	35,562	–	–	0.03%	49
2019 Q1	$6.1M	Hold	35,562	–	–	0.04%	46
2018 Q4	$5.12M	Hold	35,562	–	–	0.04%	55
2018 Q3	$11.4M	Hold	35,562	–	–	0.07%	48
2018 Q2	$12.7M	Buy	+35,562	New	+$11M	0.07%	51

Other funds holding ASLN

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Shay Capital New York $1.2B AUM 37.4% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Marex Group London $15.8B AUM 31.44% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Temasek Holdings's ASLN Position: Q1 2024 in Review

Temasek Holdings sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q1 2024, closing a stake of 1,960 shares — an estimated $8.19K sold.

Temasek Holdings first reported a position in ASLN in Q2 2018 and held it in 23 quarters. The position peaked at $12.7M in Q2 2018. 22 funds tracked by Wall St. Rank hold ASLN as of Q1 2024.

Temasek Holdings reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q1 2024 after selling out during the quarter.
Temasek Holdings sold 1,960 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q1 2024, an estimated $8.19K.
Temasek Holdings first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q2 2018 and held it in 23 quarters.
Temasek Holdings's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $12.7M in Q2 2018.
22 funds tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q1 2024.

Based on Temasek Holdings's 13F filing for Q1 2024, filed 15 May 2024.